COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1023.9 | 9 | 0208-0667 | 123.12 | 666.61 | 455 | 80.67 | 0.879 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 245.9 | 9 | 0209-0669 | 561.54 | 668.87 | 382 | 72.43 | 0.915 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 259.9 | 9 | 0210-0676 | 20.62 | 676.36 | 402 | 73.84 | 0.926 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 237.3 | 9 | 0211-0678 | 512.28 | 677.79 | 408 | 75.50 | 0.900 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1304.2 | 9 | 0212-0678 | 676.22 | 677.75 | 470 | 82.08 | 0.877 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 741.2 | 9 | 0213-0694 | 165.23 | 693.52 | 415 | 76.91 | 0.882 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1450.8 | 9 | 0214-0699 | 536.83 | 699.76 | 921 | 117.30 | 0.841 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 822.0 | 9 | 0215-0693 | 258.74 | 693.52 | 405 | 75.26 | 0.899 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 295.2 | 9 | 0216-0696 | 605.92 | 696.41 | 379 | 73.84 | 0.873 |
COLO 858 | Vemurafenib | 0.1 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 288.4 | 9 | 0217-0700 | 784.99 | 699.49 | 381 | 74.67 | 0.859 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 252.2 | 1 | 0001-0030 | 45.07 | 30.65 | 419 | 80.67 | 0.809 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 407.5 | 1 | 0002-0042 | 167.76 | 42.28 | 443 | 77.60 | 0.925 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 400.1 | 1 | 0003-0041 | 625.93 | 41.06 | 415 | 75.01 | 0.927 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 523.2 | 1 | 0004-0042 | 714.23 | 42.07 | 387 | 73.01 | 0.912 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 502.2 | 1 | 0005-0046 | 412.33 | 45.77 | 490 | 84.57 | 0.861 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 382.5 | 1 | 0006-0048 | 453.57 | 48.42 | 492 | 82.08 | 0.918 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 355.2 | 1 | 0007-0053 | 567.12 | 53.63 | 471 | 82.08 | 0.878 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 555.4 | 1 | 0008-0063 | 182.59 | 62.93 | 485 | 84.33 | 0.857 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 1667.9 | 1 | 0009-0067 | 34.57 | 67.11 | 550 | 86.91 | 0.915 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 395.6 | 1 | 0010-0075 | 78.32 | 74.79 | 442 | 77.84 | 0.917 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 595.2 | 1 | 0011-0073 | 829.94 | 73.27 | 221 | 56.53 | 0.869 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 382.4 | 1 | 0012-0088 | 611.67 | 88.17 | 454 | 79.26 | 0.908 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 456.2 | 1 | 0013-0088 | 502.07 | 88.60 | 548 | 90.77 | 0.836 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 409.9 | 1 | 0014-0086 | 852.50 | 87.02 | 282 | 66.53 | 0.801 |
COLO 858 | Vemurafenib | 0.316 | uM | 48 | hr | | | Cycle-2 | Rb (pS807; pS811); Rb (pS807); Rb (pS811) / clone D20B12 / Alexa Fluor 555 | rabbit IgG(H+L) / goat / cross-adsorbed | Cy3 | Rb (pS807; pS811) | | 509.7 | 1 | 0015-0091 | 719.29 | 91.65 | 462 | 80.08 | 0.905 |